Article
SSTR5 P335L monoclonal antibody differentiates pancreatic neuroendocrine neuroplasms with different SSTR5 genotypes.
Surgery - 1 Dec 2011
Zhou Guisheng, Gingras Marie-Claude, Liu Shi-He, Sanchez Robbi, Edwards Dean, Dawson David, Christensen Kurt, Paganelli Giovanni, Gibbs Richard, Fisher William, Brunicardi Francis C
Abstract excerpt
BACKGROUND: Somatostatin receptor type 5 (SSTR5) P335L is a hypofunctional, single nucleotide polymorphism of SSTR5 with implications in the diagnostics and therapy of pancreatic neuroendocrine neoplasms. The purpose of this study is to determine whether a SSTR5 P335L-specific monoclonal antibody could sufficiently differentiate pancreatic neuroendocrine neoplasms (PNENs) with different SSTR5 genotypes. METHODS:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
